|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
1 Division of Eukaryotic Molecular Genetics, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK
2 Section of Gene Function and Regulation, The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London SW3 6JB, UK
3 Département de Biologie du Développement, CNRS URA 1947, Institut Pasteur, 25 Rue du Docteur Roux, 75724 Paris Cedex 15, France
* Present address: Molecular Physiology, The University of Edinburgh, Wilkie Building, Medical School, Teviot Place, Edinburgh EH8 9AG, UK
These authors contributed equally
Author for correspondence (e-mail: p.rigby{at}icr.ac.uk)
Accepted 3 June 2002
Vertebrate myogenesis is controlled by four transcription factors known as the myogenic regulatory factors (MRFs): Myf5, Mrf4, myogenin and MyoD. During mouse development Myf5 is the first MRF to be expressed and it acts by integrating multiple developmental signals to initiate myogenesis. Numerous discrete regulatory elements are involved in the activation and maintenance of Myf5 gene expression in the various muscle precursor populations, reflecting the diversity of the signals that control myogenesis. Here we focus on the enhancer that recapitulates the first phase of Myf5 expression in the epaxial domain of the somite, in order to identify the subset of cells that first transcribes the gene and therefore gain insight into molecular, cellular and anatomical facets of early myogenesis. Deletion of this enhancer from a YAC reporter construct that recapitulates the Myf5 expression pattern demonstrates that this regulatory element is necessary for expression in the early epaxial somite but in no other site of myogenesis. Importantly, Myf5 is subsequently expressed in the epaxial myotome under the control of other elements located far upstream of the gene. Our data suggest that the inductive signals that control Myf5 expression switch rapidly from those that impinge on the early epaxial enhancer to those that impinge on the other enhancers that act later in the epaxial somite, indicating that there are significant changes in either the signalling environment or the responsiveness of the cells along the rostrocaudal axis. We propose that the first phase of Myf5 epaxial expression, driven by the early epaxial enhancer in the dermomyotome, is necessary for early myotome formation, while the subsequent phases are associated with cytodifferentiation within the myotome.
Key words: Epaxial, Myf5, Myogenesis, Somite, Dermomyotome, Myotome, Mouse
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  D. A. Hutcheson, J. Zhao, A. Merrell, M. Haldar, and G. Kardon Embryonic and fetal limb myogenic cells are derived from developmentally distinct progenitors and have different requirements for {beta}-catenin Genes & Dev., April 15, 2009; 23(8): 997 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Carvajal, A. Keith, and P. W.J. Rigby Global transcriptional regulation of the locus encoding the skeletal muscle determination genes Mrf4 and Myf5 Genes & Dev., January 15, 2008; 22(2): 265 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Buchberger, D. Freitag, and H.-H. Arnold A homeo-paired domain-binding motif directs Myf5 expression in progenitor cells of limb muscle Development, March 15, 2007; 134(6): 1171 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Borello, B. Berarducci, P. Murphy, L. Bajard, V. Buffa, S. Piccolo, M. Buckingham, and G. Cossu The Wnt/{beta}-catenin pathway regulates Gli-mediated Myf5 expression during somitogenesis Development, September 15, 2006; 133(18): 3723 - 3732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bajard, F. Relaix, M. Lagha, D. Rocancourt, P. Daubas, and M. E. Buckingham A novel genetic hierarchy functions during hypaxial myogenesis: Pax3 directly activates Myf5 in muscle progenitor cells in the limb Genes & Dev., September 1, 2006; 20(17): 2450 - 2464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Nakagawa, M. Arnold, M. Nakagawa, H. Hamada, J. M. Shelton, H. Kusano, T. M. Harris, G. Childs, K. P. Campbell, J. A. Richardson, et al. Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2 Genes & Dev., September 1, 2005; 19(17): 2066 - 2077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. McDermott, M. Gustafsson, T. Elsam, C.-C. Hui, C. P. Emerson Jr, and A.-G. Borycki Gli2 and Gli3 have redundant and context-dependent function in skeletal muscle formation Development, January 15, 2005; 132(2): 345 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Borue and D. M. Noden Normal and aberrant craniofacial myogenesis by grafted trunk somitic and segmental plate mesoderm Development, August 15, 2004; 131(16): 3967 - 3980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Petropoulos, P. J. Gianakopoulos, A. G. Ridgeway, and I. S. Skerjanc Disruption of Meox or Gli Activity Ablates Skeletal Myogenesis in P19 Cells J. Biol. Chem., June 4, 2004; 279(23): 23874 - 23881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Teboul, D. Summerbell, and P. W.J. Rigby The initial somitic phase of Myf5 expression requires neither Shh signaling nor Gli regulation Genes & Dev., December 1, 2003; 17(23): 2870 - 2874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Sacks, G. M. Cann, W. Nikovits Jr, S. Conlon, N. R. Espinoza, and F. E. Stockdale Regulation of myosin expression during myotome formation Development, August 1, 2003; 130(15): 3391 - 3402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hadchouel, J. J. Carvajal, P. Daubas, L. Bajard, T. Chang, D. Rocancourt, D. Cox, D. Summerbell, S. Tajbakhsh, P. W. J. Rigby, et al. Analysis of a key regulatory region upstream of the Myf5 gene reveals multiple phases of myogenesis, orchestrated at each site by a combination of elements dispersed throughout the locus Development, August 1, 2003; 130(15): 3415 - 3426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Buchberger, N. Nomokonova, and H.-H. Arnold Myf5 expression in somites and limb buds of mouse embryos is controlled by two distinct distal enhancer activities Development, July 15, 2003; 130(14): 3297 - 3307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Brend, J. Gilthorpe, D. Summerbell, and P. W. J. Rigby Multiple levels of transcriptional and post-transcriptional regulation are required to define the domain of Hoxb4 expression Development, June 15, 2003; 130(12): 2717 - 2728. [Abstract] [Full Text] [PDF]
|
|
